
Keryx announces positive interim results for mid stage trial drug for diabetic nephropathy treatment
Keryx Biopharmaceuticals (KERX) Announces Positive Interim Results From Phase 2 Clinical Study For KRX-101 (Sulodexide Gelcaps) For Treatment Of Diabetic Nephropathy.
